SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 13th, 2022 • Oncocyte Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledApril 13th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April ___, 2022, between Oncocyte Corporation, a California corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).